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Abstract
The antimicrobial activities of garlic and other plant alliums are primarily based on allicin,
a thiosulphinate present in crushed garlic bulbs. We set out to determine if pure allicin
and aqueous garlic extracts (AGE) exhibit antimicrobial properties against the
Burkholderia cepacia complex (Bcc), the major bacterial phytopathogen for alliums and
an intrinsically multiresistant and life-threatening human pathogen.We prepared an AGE
from commercial garlic bulbs and used HPLC to quantify the amount of allicin therein
using an aqueous allicin standard (AAS). Initially we determined the minimum inhibitory
concentrations (MICs) of the AGE against 38 Bcc isolates; these MICs ranged from 0.5
to 3% (v/v). The antimicrobial activity of pure allicin (AAS) was confirmed by MIC and
minimum bactericidal concentration (MBC) assays against a smaller panel of five Bcc
isolates; these included three representative strains of the most clinically important
species,B. cenocepacia. Time kill assays, in the presence of ten timesMIC, showed that
the bactericidal activity of AGE and AAS against B. cenocepacia C6433 correlated with
the concentration of allicin. We also used protein mass spectrometry analysis to begin to
investigate the possible molecular mechanisms of allicin with a recombinant form of a
thiol-dependent peroxiredoxin (BCP, Prx) from B. cenocepacia. This revealed that AAS
and AGE modifies an essential BCP catalytic cysteine residue and suggests a role for
allicin as a general electrophilic reagent that targets protein thiols. To our knowledge, we
report the first evidence that allicin and allicin-containing garlic extracts possess inhibitory
and bactericidal activities against the Bcc. Present therapeutic options against these life-
threatening pathogens are limited; thus, allicin-containing compoundsmerit investigation
as adjuncts to existing antibiotics.
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Introduction
There are spices and vegetables that can grow
Some are under the ground, some grow tall
Though they all have their qualities, this you should know
That the garlic is best of them all
Ruthie Gordon, The Garlic Waltz (1980)
The various medicinal properties of garlic (Allium sativum L.) and other alliums
have long been recognised; nevertheless, these properties and their modus operandi
remain enigmatic [1]. The antimicrobial activity derived from alliums was
identified nearly 70 years ago and subsequently the chemical structure of allicin
(2-propenylthiosulphinate, figure 1) and its properties elucidated over a series of
papers by researchers at The Winthrop Chemical Company [2–5]. More recent
analyses revealed that allicin accounts for approximately 75% of garlic-derived
sulphinates [1, 6–9]. Amongst over 600 allium species, most attention has been
paid to aqueous extracts of garlic which are particularly rich in allicin. In freshly
prepared garlic homogenate, allicin is derived de novo by the action of the
pyridoxal 59-phosphate-containing enzyme, alliinase, on the non-protein amino
acid, alliin (Figure 1) [10]. Unfortunately, the instability of allicin in the presence
of other garlic-derived compounds has hampered attempts to distinguish between
the antibacterial role of alliin, allicin and other sulfur-rich antibacterial
compounds in plant extracts. In addition, most medicinal garlic supplements sold
as garlic powder tablets or capsules show poor allicin release [7]. The
mechanism(s) through which allicin and other garlic compounds inhibit or kill
bacteria also remain unclear. Studies on inhibition of Salmonella typhimurium
using allicin prepared from reacting alliin with alliin lyase suggested that
inhibition of RNA synthesis is a primary target of allicin action [11]. Allicin and
other thiosulphinates are also known to react with cysteine to abolish
antimicrobial activity [12] and to inhibit acetyl-CoA synthases from plants, yeasts
and mammals [13]. A recent review highlights the chemical and biological
properties of allicin [14].
Most previous studies of the antibacterial activity of garlic extracts have focused
on Escherichia coli and Staphylococcus aureus. Ajoene, a lipid-soluble allyl sulphide
derivative of allicin, found in oil-derived garlic extracts has been reported to cause
broad spectrum microbial growth inhibition [15]. Recently, ajoene has also been
shown to inhibit quorum sensing in P. aeruginosa [16, 17]. Interestingly, we could
find no published studies of the antimicrobial properties of garlic-related
compounds on the Burkholderia cepacia complex (Bcc), a group of 17 closely-
related species distributed widely in soil, water and the plant rhizosphere [18].
This is both surprising and ironic since as well as being important agents for
bioremediation and biological control [19, 20] the Bcc are the major phyto-
pathogens for allium species [21].
In the last few decades, the Bcc have also emerged as important opportunistic
human pathogens, in particular as a cause of life-threatening lung infections in
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individuals with cystic fibrosis (CF) and chronic granulomatous disease [22, 23].
Although patient segregation and strict infection control have reduced the
incidence of Bcc infections in individuals with CF, such infections remain an
important clinical problem. At present, the most predominant Bcc species
responsible for CF infections are B. cenocepacia and B. multivorans [22, 24]. Most
transplant centres worldwide exclude individuals infected by B. cenocepacia from
access to lung transplantation, the only proven treatment for severe CF lung
disease. Thus, any new strategies that lead to the improved eradication of Bcc
from an infected patient would be important. Unfortunately, a common feature of
the Bcc is intrinsic resistance to most antibiotics [25]; hence antibiotic treatment
presents a major challenge. To our knowledge, there have been only five case
reports of successful antibiotic therapy for cepacia syndrome, the acute potentially
fatal septicaemia and necrotising pneumonia caused by Bcc. These reports
emphasise the need for prolonged treatment with IV and aerosolised antibiotic
combinations which include ceftazidime, ciprofloxacin, tobramycin, temocillin
and trimethoprim-sulphamethoxazole [26, 27]. At present, there is insufficient
data to support the use of any specific antibiotic regimen against Bcc infection
[28, 29]. There is an even greater need to have alternative therapies with the recent
alarming report of a clinical trial of inhaled aztreonam that failed to treat CF
patients with Burkholderia spp. infection [30, 31]. Thus, the availability of novel
antimicrobial agents against Bcc would represent a major clinical advance for
patients with Bcc infection.
Given the dearth of new antibiotics from conventional approaches within the
pharmaceutical industry, the development of novel antimicrobial compounds
derived from natural sources would be welcomed [32, 33]; this is particularly
relevant to the management of lung infections which are the primary cause of
morbidity and mortality in the CF population. As previously indicated, the
therapeutic potential and complex chemistry of alliums is well documented but
remains enigmatic [1, 6]. In our study, we have employed a multidisciplinary
approach using both analytical chemistry and microbiology to investigate the
Figure 1. Chemical structure of allicin and mechanism of formation from alliin by the enzyme alliinase.
Step 1. Alliinase hydrolyses alliin to produce allylsulfenic acid which, in step 2, condenses spontaneously with
the loss of water to produce allicin.
doi:10.1371/journal.pone.0112726.g001
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antimicrobial properties of a pure aqueous allicin standard (AAS) and aqueous
garlic extracts (AGE). Our data demonstrates that the antimicrobial potential of
allicin-containing plant extracts is worth revisiting.
Materials and Methods
Quantitative RP-HPLC analyses
Allicin standard was purchased from LKT Laboratories, Minnesota as a
preparation with 98% purity and was stored at 280 C˚ until used. AGE
preparations were prepared from 30 g crushed garlic bulb and 30 ml sterile,
distilled water as described by Fujisawa et. al. 2008 [6]. We used a method based
on that published by Lawson and Wang to analyse the allicin content in the AAS
and AGE [7]. We prepared a 1000 mg/ml AAS stock solution and carried out serial
dilutions to obtain standards that ranged from 8–1000 mg/mL to calibrate the RP-
HPLC method (Column dimensions: 25064.6 mm, 3.6 m, C18 Aeris Peptide
from Phenomenex). The elution conditions used were: isocratic elution with
MeOH/water (60:40, v/v) at 1 ml/min with UV detection at 240 nm, 25 C˚. An
injection volume of 20 mL was used for all samples. The mass of the AAS was
confirmed using direct infusion mass spectrometry. Typically, AAS was analysed
at a concentration of 10 mM from a solution of water/acetonitrile (50:50, v/v).
Spectral data was collected on an electrospray micro-ToF mass spectrometer
(Bruker) operating in the positive mode.
Antimicrobial assays
In a preliminary survey, we investigated the minimum inhibitory concentrations
(MICs) of AGE by agar dilution against 38 Bcc isolates representing nine Bcc
species and which included 30 isolates from an experimental Bcc strain panel [34].
The MICs and minimum bactericidal concentrations (MBCs) of allicin standard
(AAS) against five members of the BCC strain panel were determined by the
microtitre broth technique recommended by the NCCLS [35]. Time kill assays
were then performed on a single Bcc isolate, B. cenocepacia C6433, with an initial
bacterial inoculum of 106 CFU/mL and with AGE and AAS at concentrations ten
times MICs. To provide further information on suitable screening assays,
susceptibility to AGE was investigated by agar well diffusion and impregnated
paper disc diffusion analysis [6]. Isosensitest agar (Oxoid Ltd., Basingstoke, UK)
plates were flood seeded using a log phase 106 CFU/mL isosensitest broth culture
of C6433. 10 mL undiluted AGE was added to a well cut in the agar or used to
impregnate sterile paper discs. Antimicrobial activity was determined by a zone of
inhibition after overnight incubation at 37 C˚ (Figure S1).
Modification of recombinant B. cenocepacia BCP by AAS and AGE
The His-tagged B. cenocepacia J2315 bacterioferritin comigratory protein (BCP)
peroxiredoxin (Prx), which is also referred to as ‘‘peroxidase’’, was overexpressed
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in E. coli and purified and stored as described by Clarke et. al. [36] The purified
BCP protein (10 mM) was incubated with AAS (0.1 mM and 1 mM) at 37 C˚ for 1,
5, 30, 60, 120 and 180 mins. Each reaction was quenched with 0.1% formic acid
and then analysed by electrospray ionisation Fourier transform ion cyclotron
resonance mass spectrometry (ESI FT-ICR MS). Freshly-prepared AGE (3.38 mg/
mL was passed through a PD-10 (Sephadex G-25M) desalting column, the low
molecular weight fraction was collected and incubated with BCP (50 mM) for 1, 5,
30, 60, 120 and 180 mins at 37 C˚. To isolate the enzyme from the incubation
mixture, the sample was then shaken with Ni-NTA resin for 50 mins followed by
elution of the protein from the resin with 300 mM imidazole. Excess imidazole
was removed from protein samples by PD-10 desalting which were then
concentrated to 2 mL and analysed by ESI FT-ICR MS.
Protein Mass Spectrometry Analysis
Protein samples were analysed by LC-MS using an Ultimate 3000 HPLC system
(Dionex Corporation, Sunnyvale, CA), equipped with a monolithic PS-DVB
(500 mm65 mm) analytical column (Dionex Corporation). Mobile phases A and
B comprised 2:97.95 and 80:19.95 acetonitrile:water with 0.05% formic acid
respectively (v/v/v). Samples were injected onto the analytical column, washed
with buffer A for 5 min, followed by a 20 min linear gradient elution (20 ml/min)
into buffer B. MS data was acquired on a Bruker 12 Tesla Apex Qe FT-ICR
(Bruker Daltonics, Billerica, MA). Desolvated ions were detected between m/z 600
and 2000 for 0.5 s to yield a broadband 512 Kword time-domain data. Fast
Fourier Transforms and subsequent analyses were performed using DataAnalysis
(Bruker Daltonics) software. All m/z spectra were deconvoluted using MaxEnt
software in DataAnalysis (Bruker Daltonics).
Results
Quantification of allicin in AGE
The purity of AAS was confirmed using a published RP-HPLC method (Fig. 2A)
[7]. Allicin eluted with a retention time of 4.1 min and an observed m/z of
185.0067 (consistent with the [M+Na]+ species; theoretical m/z 185.0065;
[C6H10OS2+Na]+) (Fig. 2A inset). Using the same HPLC conditions, the elution
profile of AGE contained several well-resolved peaks (Fig. 2B), and the peak
eluting at 4.1 min was identified as allicin by mass spectrometry (m/z 185.0067;
[M+Na]+). A calibration curve was obtained by analysing known concentrations
of AAS (8–1000 mg/mL) and used to quantify the amount of allicin present in the
fresh AGE preparations (Fig. 3). The peak area for allicin was linear over 0–20 g of
allicin loaded onto the column (r250.9987 and gradient 0.57¡0.01 mAU.min.
mg21) and the amount of allicin in freshly prepared AGE was determined as
67.6¡7.9 mg in 20 ml, which equates to 3.386103¡0.39 mg/mL (allicin/AGE, w/
v).
Antimicrobial Activity of Allicin against a Panel of Burkholderia
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Antimicrobial activity
AGE displayed antimicrobial activity against all of the 38 Bcc isolates (Table 1)
with MICs ranging from 0.5 to 3%, where 100% equates to 10 g of garlic bulb
homogenised in 10 ml of sterile, distilled water. Interestingly, comparison of the
antimicrobial activity of four independent AGE preparations showed little batch-
to-batch variation (data not shown). Activity also remained stable when AGE was
stored at 4 C˚ for seven days or for at least 6 months at 280 C˚. We noted that the
epidemic, clinically-relevant isolate B. cenocepacia C6433 was sensitive (0.5%) to
AGE. So in further experiments, the inhibitory activity of AGE was confirmed
with impregnated paper discs and agar well diffusion assays using an inoculum of
10 ml (106 CFU/ml) per disc or well (Figure S1). Since the amount of pure allicin
(AAS) available was limited, investigation of the antimicrobial activity of AAS was
restricted to MIC and MBC assays using five Bcc isolates (table 2). MICs ranged
from 8 to 62 mg/mL and MBCs 31 to 62 mg/mL. In time-kill assays, bactericidal
activities of AGE and AAS against B. cenocepacia C6433 were 99.9% and 100%
respectively within 12 h (data not shown). Since the MIC of AGE required for
inhibition of B. cenocepacia C6433 is 0.5%, we used our quantification of allicin in
garlic preparations (Fig. 3) to determine that this dilution of AGE contains
Figure 2. HPLC and MS analysis of aqueous allicin standard (AAS) and aqueous garlic extract (AGE).
(A) AAS was analysed using a C18 reverse phase column with UV detection at 240 nm. The standard eluted
at 4.1 minutes. AAS had an observed m/z of 185.0067 (consistent with the [M+Na]+ species; theoretical m/z
185.0065; [C6H10OS2+Na]+) (inset). (B) AGE was analysed by the same method as described for AAS. The
peak at 4.1 minutes corresponds to the mass of allicin.
doi:10.1371/journal.pone.0112726.g002
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,16.9 mg/mL allicin. This analysis now allows comparison with the MIC of pure
allicin (AAS) against this B. cenocepacia isolate, which we determined as 4 mg/mL
allicin. These observations suggest that, against this isolate, allicin is the major
antibacterial species in the AGE preparation.
Interaction of BCP with allicin and AGE
The exact chemical mechanism(s) by which allicin exerts its antibacterial
activity has been the subject of numerous studies and it’s chemical structure
suggests it should react with free thiols. Indeed, allicin is known to covalently
modify the free amino acid L-cysteine via formation of allyl-disulfide species
[37]. Therefore, we postulate that the antimicrobial activity of allicin is derived
from modification of cysteine residues found in key metabolic proteins within
Burkholderia. In order to test this hypothesis we have studied the reaction of
AAS and AGE with the enzyme BCP, a peroxiredoxin (Prx) which is known to
contain catalytically important cysteine residues (Cys44 and Cys98) [36]. We
use this protein as an example of cysteine-containing proteins within the B.
cenocepacia proteome and not as the sole target of allicin within the organism.
The interaction between AAS and the recombinant BCP was studied by mass
spectrometry. The unmodified BCP has a mass of 18992 Da which confirmed
that both cysteine residues are in the reduced (-SH) form (Fig. 4A). Upon
incubation of the BCP with AAS (1 mM or 161 mg/ml) for 60 minutes we
noted the appearance of two new species with masses of 19064 and 19136 Da (
Fig. 4B). These observed increases in mass (D72 and D144 Da) are consistent
with the addition of a single allyl thiol group (C3H5S) to either one or both
cysteine residues (Fig. 4D). This result is not surprising as allicin is expected to
react with the free thiols on BCP in a non-specific manner as shown by
previous studies with cysteine, glutathione and papain [12, 37]. Importantly,
Figure 3. Calibration curve of aqueous allicin standard (AAS). AAS of known concentrations (8–1000 mg/
mL) were used to produce a calibration curve which was then used to quantify the allicin present in the fresh
AGE preparations. The peak area for allicin was linear over 0–20 mg of allicin loaded onto the column
(r250.9987 and gradient 0.57¡0.01 mAU.min. mg21).
doi:10.1371/journal.pone.0112726.g003
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similar mass increases were observed when we incubated the BCP with AGE for
60 minutes (Fig. 4C). This important experiment confirms that the AGE and
the AAS react with the protein target in the same manner (Fig. 4D).
Table 1. MICs (mg/ml) of AGE for B. cepacia complex.
Strain Edinburgh Lab No. LMG No. *Strain Name AGE (%)
B. cepacia J673 1222 ATCC 25416 2
B. cepacia J675 2161 ATCC 2161 1
B. cepacia C2970 17997 0.5
B. cepacia C3159 18821 CEP509 0.5
B. multivorans C1576 16660 0.5
B. multivorans C1962 16665 0.5
B. multivorans C3160 18822 C5393 1
B. multivorans C3161 13010 1
B. multivorans C3162 18825 CF-A1-1 1
B. multivorans C3163 18824 JTC 0.5
B. multivorans C3164 18823 249-2 0.5
B. multivorans J2511 17588 ATCC 17616 1
B. cenocepacia J415 16654 1
B. cenocepacia C1394 16659 1
B. cenocepacia J2315 16656 0.5
B. cenocepacia J2524 18832 ATCC 17765 3
B. cenocepacia C3165 18826 BC7 0.5
B. cenocepacia C3166 18863 K56-2 1
B. cenocepacia C3167 18827 C5424 0.5
B. cenocepacia C3168 18828 C6433 0.5
B. cenocepacia C3169 18829 PC184 0.5
B. cenocepacia C3170 18830 CEP511 1
B. stabilis C3171 14294 0.5
B. stabilis C3172 18870 C7322 0.5
B. stabilis C3173 18888 1
B. stabilis C3174 14086 1
B. vietnamiensis C2978 16232 1
B. vietnamiensis C3175 18835 PC259 1
B. vietnamiensis C3176 18836 FC441 3
B. vietnamiensis C3177 10929 1
B. dolosa J3357 1
B. dolosa J3358 1
B. ambifaria J3361 2
B. ambifaria J3362 1
B. anthina J3364 1
B. anthina J3366 1
B. pyrrocinia J3368 2
B. pyrrocinia J3369 0.5
* We have included all codes to avoid confusion between Edinburgh strain collection numbers, LMG and ATCC codes.
doi:10.1371/journal.pone.0112726.t001
Antimicrobial Activity of Allicin against a Panel of Burkholderia
PLOS ONE | DOI:10.1371/journal.pone.0112726 December 1, 2014 8 / 13
Discussion
Production of antimicrobial compounds by plant alliums which target
Burkholderia species, their principal bacterial pathogen, is not surprising.
However, what is surprising is that, to our knowledge; such activity has not been
reported or investigated previously. We report the first evidence for the
antimicrobial activity of allicin against the Bcc. The MICs and MBCs of allicin-
containing preparations against BCC isolates were commensurate with breakpoint
values for antibiotics in present clinical use. Encouragingly, killing activity
includes B. cenocepacia, the most prevalent and transmissible Bcc species isolated
from CF infections [22, 24]. In general, Bcc isolates exhibit intrinsic resistance to
antimicrobial peptides and other antibiotics [25, 38, 39]. Thus, treatment of Bcc
infections remains challenging and no particular antibiotic regimen is presently
recognised [26, 40].
The chemical mechanisms involved in the bactericidal action of allicin are
poorly understood, and in the case of the Bcc are unknown. Given previous
evidence that allicin preferentially interacts with cysteine, our hypothesis is that
the allylthio moiety of allicin allows it to react with cysteine-containing
Burkholderia enzymes involved in key biosynthetic pathways. The exact targets of
allicin are not known but we assume there will be many proteins that have the
potential to be modified. As a relevant model protein, we used the Bcc-derived
peroxidase enzyme, BCP peroxiredoxin, which we have previously shown plays a
role in the detoxification of reactive oxygen species (ROS) within B. cenocepacia
[36]. In that study we also identified that Cys44 and Cys98 are essential for the
optimal catalytic activity of the enzyme, therefore any chemical modification of
these residues will inactivate the enzyme. We chose mass spectrometry as the
analytical tool for BCP/allicin analysis since BCP ionises well and mass
spectrometry is ideally suited to measure covalently-bound adducts.
Our data strongly suggests that pure allicin (AAS) and, more importantly, the
allicin within AGE react with both Cys44 and Cys98 residues of BCP to give
modified isoforms of masses 19064 Da and 19136 Da. These observed mass
increases of 72 and 144 Da correspond to the addition of one and two allylthio
groups respectively by reaction with allicin (Fig. 4D). The proposed mechanism
for the formation of the BCP-allythio derivative involves nucleophilic attack of a
BCP cysteine thiol (either Cys44 or Cys98) on the more electrophilic sulfur of
allicin to produce a new disulfide bond. A second molecule of allicin undergoes a
Table 2. MICs and MBCs (mg/ml) of AAS for B. cepacia complex.
Strain Edinburgh Lab No. LMG No. MIC MBC
B. cenocepacia J2315 16656 8 31
B. cenocepacia C6433 18828 8 31
B. cenocepacia C3165 18826 16 31
B. stabilis C3172 18870 16 31
B. cepacia J673 1222 62 62
doi:10.1371/journal.pone.0112726.t002
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similar reaction to add a second allylthio group. Reduction of the derivitised BCP
with excess reducing agent (tris (2-carboxyethyl) phosphine, TCEP) returned the
enzyme to the unmodified form (18992 Da) which suggests that the reaction of
allicin with BCP is chemically reversible in the presence of strong reducing agents
(data not shown). The results from the proteomic analysis of BCP with the AGE
was very unexpected, as garlic extract is a complex mixture as observed from our
HPLC analysis. This clearly-resolved data confirms that allicin is the main
component of freshly prepared garlic that reacted with BCP (Fig. 4C). More
importantly, this is the first study where AAS and AGE have been analysed by
protein mass spectrometry with a relevant protein target from a bacterial
pathogen. We think that this study opens the door to apply this powerful
analytical tool for identifying many of the protein targets that are modified by
allicin within the proteome of Burkholderia and other pthogens. It could also
prove useful to study other similar allylthio-containing natural products (e.g.
ajoene) derived from allicin.
Previous investigations of novel antimicrobial compounds against Bcc species
have included mushroom extracts [41], polyketides [42], docosahexaenoic
omega- 3 fatty acid [43] and microbe-derived volatile organic compounds [44].
Figure 4. MS analysis of recombinantly produced Burkholderia cepacia BCP Prx incubated with AAS
and AGE. (A) Purified Bc BCP Prx has a mass of 18992 Da, consistent with its predicted mass based on the
amino acid sequence (B) Bc BCP after incubation with 1 mM AAS for 1 h results in the formation of two
covalently modified species of mass increases +72 Da and +144 Da. (C) Bc BCP Prx after incubation with
AGE for 1 h results in the formation of a covalently modified species of mass increase +144 Da corresponding
to the addition of two allicin adducts. * denotes enzyme species that undergo a-N-gluconoylation during
protein expression. (D) Proposed mechanism of reaction of allicin with Bc BCP Prx.
doi:10.1371/journal.pone.0112726.g004
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Our results demonstrating the inhibitory activity of allicin-containing garlic
extracts against Burkholderia species provide another potential line of research
that is particularly relevant to Bcc infection. Evidence from animal and human
studies have shown that allicin-containing garlic homogenates, delivered orally,
intravenously or intraperitoneally, act as potent antioxidants leading to reduction
of neutrophil-mediated lung damage, a major mechanism of Bcc lung infection
[45]. The stability of the antimicrobial properties of AGE during storage at 4 C˚
and 280 C˚ coupled with the batch-to-batch reproducibility were notable.
Similarly, the rapid therapeutic action of garlic homogenates in serum and plasma
in the treatment of cardiovascular disorders [46, 47] could be a particular
advantage in the treatment of the life-threatening septicaemia that is characteristic
of cepacia syndrome. Our investigation suggests that further work is required to
comprehensively describe the antimicrobial mechanisms of allicin and to assess
allicin-containing formulations as adjuncts to conventional antimicrobial agents
presently used against this challenging group of bacterial pathogens.
Supporting Information
Figure S1. Zones of inhibition against B. cenocepacia C6433 produced by AGE-
impregnated disc (left) and AGE-containing agar well (right). Isosensitest agar
plates were flood seeded using a 106 CFU/mL isosensitest broth culture of C6433.
10 mL undiluted AGE was added to a well cut in the agar or used to impregnate
sterile paper discs. We note the lack of resistant mutants.
doi:10.1371/journal.pone.0112726.s001 (TIF)
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